Werthstein US Stock Exchange

Deals

Immunic merges and goes public on the US stock exchange

Clever leap onto the US stock exchange: Through a merger with the Nasdaq-listed company Vital Therapies, the Martinsried-based…

Biotech Press Lounge 2018

ecosystem

Biotech Press Lounge: New ways to invest in cancer drugs

The Biotech Press Lounge has established itself as a networking event for the Martinsried Science Campus. Over 100 guests from the biotech, pharmaceutical, and…

Speakers at the Biotech Press Lounge on October 12, 2017, at the IZB (from left to right): Dr. Markus Dangl, Senior Vice President Research and Pre-Clinical Development, Medigene AG; Evelyn Warner, Editor-in-Chief, LaBiotech.eu; Dr. Jens Altrichter, COO Leukocare AG; Dr. Peter Hanns Zobel, Managing Director IZB; PhD. Paola Casarosa, Corporate Vice President Therapeutics, Böhringer Ingelheim

Accelerator/Incubator

Biotech Press Lounge: IZB startups working on medical progress

On October 12, 2017, the Innovation and Startup Center for Biotechnology (IZB) hosted the sixth Biotech Press Lounge at the Faculty Club G2B…

Life Science Pitch Day IZB

ecosystem

3rd Munich Life Science Pitch Day at the IZB

The High-Tech Gründerfonds (HTGF), Bayer Pharma AG, Merck KGaA and the Innovation and Start-up Center for Biotechnology (IZB) have…

IZB Team

ecosystem

The team must be on fire! – Asked by… IZB

The IZB in Martinsried has existed since 1995. Since then, the innovation center for biotechnology has produced many successful companies,…

IZB Biotech Press Lounge

Deals

Over 50 million euros for IZB companies

On October 13, the Innovation and Start-up Center for Biotechnology (IZB) hosted the third Biotech Press Lounge in the Faculty Club G2B (Gateway…

Immunic

Deals

Immunic receives 17.5 million euros in financing

Immunic AG, a young, privately held biotech company in Planegg-Martinsried near Munich, has successfully completed its first financing round (series…

Eisbach Bio Pieris Pharmaceuticals Financing

Interviews

“The mood in the Bavarian biotech startup landscape is very good” – Interview with Prof. Dr. Horst Domdey

Around EUR 630 million flowed into companies from the IZB Martinsried last year through IPOs, financing rounds, and sales. Almost…

AMSilk

Deals

AMSilk: BioTech startup raises fresh growth capital

AMSilk GmbH, based at the IZB Martinsried, has secured new capital in a financing round. The world's first…

Science4Life

ecosystem

PreOmics wins 2nd prize at Science4Life Award

The BioM startup PreOmics, based at the IZB Martinsried, secured second place in the Science4Life Venture competition, endowed with 10,000 euros…

Biotech Press Lounge

ecosystem

2. Biotech Press Lounge at the IZB

On July 12, 2016, the Innovation and Start-up Center for Biotechnology (IZB) in cooperation with the Bavarian Biotechnology Cluster (BioM) hosted…

Accelerator/Incubator

2nd Life Science Pitch Day: Investor interest increases

The High-Tech Gründerfonds, Bayer Pharma AG, BioM Biotech Cluster Development GmbH and the Innovation and Startup Center for Biotechnology (IZB)…